Report no 279/2026
Podstawa prawna: Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
Sofia, Bulgaria, September 21, 2026 - "Sopharma" AD (SFA: "Bulgarian Stock Exchange" AD, SPH: Warsaw Stock Exchange) pursuant to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), hereby informs that in August 2026 the Company reported a 1% increase in sales compared to the same month of the previous year, including a 3% decrease in domestic sales and a 4% increase in export sales.
For the period from the beginning of 2026 through the end of August, the Company reported a 43% increase in sales compared to the same period of the previous year, including a 3% increase in domestic sales and an 68% increase in export sales.
